Inventor
BUETTNER FRANK
DE19 patents
⚠️ This page may combine multiple inventors who share the name “BUETTNER FRANK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BOEHRINGER INGELHEIM PHARMA
6 patentsUS7056916B2Jun 6, 2006
Medicaments for the treatment of chronic obstructive pulmonary disease
BOEHRINGER INGELHEIM PHARMA43 citations96
US6951888B2Oct 4, 2005
Betamimetics with a prolonged duration of activity, processes for preparing them, and their use as pharmaceutical compositions
BOEHRINGER INGELHEIM PHARMA22 citations92
US7727984B2Jun 1, 2010
Medicaments for the treatment of chronic obstructive pulmonary disease
BOEHRINGER INGELHEIM PHARMA9 citations84
US7135500B2Nov 14, 2006
Dihydroxymethylphenyl derivatives, processes for preparing them, and their use as pharmaceuticals
BOEHRINGER INGELHEIM PHARMA16 citations83
US7786111B2Aug 31, 2010
Medicaments for the treatment of chronic obstructive pulmonary disease
BOEHRINGER INGELHEIM PHARMA5 citations73
US8044046B2Oct 25, 2011
Medicaments for the treatment of chronic obstructive pulmonary disease
BOEHRINGER INGELHEIM PHARMA2 citations62
BOEHRINGER INGELHEIM INT
3 patentsUS7422845B2Sep 9, 2008
Detection of NO by using guanylyl cyclase and cGMP production as a readout system
BOEHRINGER INGELHEIM INT4 citations73
US7759054B2Jul 20, 2010
Method for detection of nitric oxide (NO)
BOEHRINGER INGELHEIM INT2 citations62
US7511067B2Mar 31, 2009
3-hydroxymethyl-4-hydroxy-phenyl-derivatives for the treatment of respiratory diseases
BOEHRINGER INGELHEIM INT0 citations51
AVENTIS PHARMA GMBH
3 patentsUS6235727B1May 22, 2001
Sulfonylaminophosphinic and sulfonylaminophosphinic acid derivatives, methods for their preparation and use
AVENTIS PHARMA GMBH4 citations62
US6500811B2Dec 31, 2002
Sulfonylaminophosphinic and sulfonylaminophosphonic acid derivatives, methods for their preparation and use
AVENTIS PHARMA GMBH0 citations52
US6180334B1Jan 30, 2001
Artificial recombinant substrate (rAGG 1) and native aggrecan to determine the proteolytic activity of ‘aggrecanase’ in cell culture systems
AVENTIS PHARMA GMBH1 citations47